Literature DB >> 7984241

A topoisomerase II-dependent G2 cycle checkpoint in mammalian cells/.

C S Downes1, D J Clarke, A M Mullinger, J F Giménez-Abián, A M Creighton, R T Johnson.   

Abstract

The enzyme DNA topoisomerase II, which removes the catenations formed between the DNA molecules of sister chromatids during replication and is a structural component of chromosome cores, is needed for chromosome condensation in yeast and in Xenopus extracts. Inhibitors of topoisomerase II arrest mammalian cells before mitosis in the G2 phase of the cell cycle, but also produce DNA damage, which causes arrest through established checkpoint controls. It is open to question whether cells need topoisomerase II to leave G2, or control late-cycle progression in response to its activity. Bisdioxopiperazines are topoisomerase II inhibitors that act without producing direct DNA damage; the most potent, ICRF-193, blocks mammalian entry into but not exit from mitosis. Here we show that checkpoint-evading agents such as caffeine override this block to produce abortively condensed chromosomes, indicating that topoisomerase II is needed for complete condensation. We find that exit from G2 is regulated by a catenation-sensitive checkpoint mechanism which is distinct from the G2-damage checkpoint.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7984241     DOI: 10.1038/372467a0

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   49.962


  106 in total

1.  Cloning and characterization of a cDNA encoding topoisomerase II in pea and analysis of its expression in relation to cell proliferation.

Authors:  M K Reddy; S Nair; K K Tewari; Y Mudgil; B S Yadav; S K Sopory
Journal:  Plant Mol Biol       Date:  1999-09       Impact factor: 4.076

2.  Synchronous nuclear-envelope breakdown and anaphase onset in plant multinucleate cells.

Authors:  J F Giménez-Abián; D J Clarke; M I Giménez-Abián; C de la Torre; G Giménez-Martín
Journal:  Protoplasma       Date:  2001       Impact factor: 3.356

3.  Mammalian Fbh1 is important to restore normal mitotic progression following decatenation stress.

Authors:  Corentin Laulier; Anita Cheng; Nick Huang; Jeremy M Stark
Journal:  DNA Repair (Amst)       Date:  2010-04-24

4.  MCPH1 is essential for cellular adaptation to the G2-phase decatenation checkpoint.

Authors:  María Arroyo; Ryoko Kuriyama; Israel Guerrero; Daniel Keifenheim; Ana Cañuelo; Jesús Calahorra; Antonio Sánchez; Duncan J Clarke; J Alberto Marchal
Journal:  FASEB J       Date:  2019-04-09       Impact factor: 5.191

5.  Effects of conditional depletion of topoisomerase II on cell cycle progression in mammalian cells.

Authors:  Ruth E Gonzalez; Chang-Uk Lim; Kelly Cole; Christine Hanko Bianchini; Gary P Schools; Brian E Davis; Ikuo Wada; Igor B Roninson; Eugenia V Broude
Journal:  Cell Cycle       Date:  2011-10-15       Impact factor: 4.534

6.  Topoisomerase II-DNA complexes trapped by ICRF-193 perturb chromatin structure.

Authors:  Thomas Germe; Olivier Hyrien
Journal:  EMBO Rep       Date:  2005-08       Impact factor: 8.807

7.  Protein kinase C delta activates topoisomerase IIalpha to induce apoptotic cell death in response to DNA damage.

Authors:  Kiyotsugu Yoshida; Tomoko Yamaguchi; Hirokuni Shinagawa; Naoe Taira; Keiichi I Nakayama; Yoshio Miki
Journal:  Mol Cell Biol       Date:  2006-05       Impact factor: 4.272

Review 8.  SUMO modification of DNA topoisomerase II: trying to get a CENse of it all.

Authors:  Ming-Ta Lee; Jeff Bachant
Journal:  DNA Repair (Amst)       Date:  2009-02-20

9.  Roles of DNA topoisomerase II isozymes in chemotherapy and secondary malignancies.

Authors:  Anna M Azarova; Yi Lisa Lyu; Chao-Po Lin; Yuan-Chin Tsai; Johnson Yiu-Nam Lau; James C Wang; Leroy F Liu
Journal:  Proc Natl Acad Sci U S A       Date:  2007-06-19       Impact factor: 11.205

10.  A mitotic topoisomerase II checkpoint in budding yeast is required for genome stability but acts independently of Pds1/securin.

Authors:  Catherine A Andrews; Amit C Vas; Brian Meier; Juan F Giménez-Abián; Laura A Díaz-Martínez; Julie Green; Stacy L Erickson; Kristyn E Vanderwaal; Wei-Shan Hsu; Duncan J Clarke
Journal:  Genes Dev       Date:  2006-05-01       Impact factor: 11.361

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.